This message was sent to ##Email## November 23, 2016     Home  |   About   Subscribe  |   Archive  |   Advertise   Resistance training improves posttreatment outcomes for breast cancer survivors Oncology Nurse Advisor Survivors of breast cancer often suffer in multiple ways from their disease, its treatment, and the side effects of both. An especially cruel consequence is the adverse effects that have the potential to further change a woman's body, leading to chronic pain, disability, and even death. The altered body composition and decreased bone mineral density (BMD) that follows cancer may result in osteopenia and osteoporosis.  READ MORE    SPONSORED CONTENT Promoted by CHAMPS Oncology insight2oncology® Turns Cancer Data into Actionable Information CHAMPS insight2oncology® and i2o® Receive Registered Trademark Reveal What i2o® Cancer Analytics Can Answer for Your Service Line i2o® Highlights Most Valuable Information for Cancer Center Administrators Discover the Power of Your Cancer Registry Data   Does dose-dense chemotherapy improve outcomes for patients with high-risk early breast cancer? Cancer Therapy Advisor Dose-dense chemotherapy, a method of administering chemotherapy at shorter intervals to decrease toxic effects, is not associated with an improvement in recurrence-free survival among patients with early-stage, high-risk breast cancer, according to a study published in JAMA. Dose-dense chemotherapy regimens yield inconsistent drug safety, efficacy and pharmacokinetic results. The objective of this study was to analyze the effects of dose-dense chemotherapy vs traditional therapy this patient population.  READ MORE ASCO launches oncology medical home model Medscape A new initiative launched by the American Society of Clinical Oncology (ASCO) aims to help community oncology practices move away from volume-based towards value-based care by structuring reimbursement around the full range of services needed by patients with cancer. It will also prepare oncology practices for full implementation of the Quality Payment Program, authorized by the Medicare Access and CHIP Reauthorization Act (MACRA) and will be available across the United States starting on Jan. 1, 2017.  READ MORE    PRODUCT SHOWCASE Advertisement Wiley's Oncology Apps Enjoy our journals? There’s an app for those! Journals such as those from the American Cancer Society ™, Journal of Surgical Oncology, Cancer Science and more are now available for your iPad and iPhone. Sample issues and abstracts, as well as open articles, can be accessed for free. A subscription to the journal is required to read the full text. AJCC Cancer Staging Manual, 8th edition The American Joint Committee on Cancer (AJCC) has released the eighth edition of its Cancer Staging Manual. This edition presents evidence‐based revisions for staging cancer for a number of organ sites and includes the rationale and rules for staging; the definitions of tumor, lymph node involvement and metastasis (TNM); stage groupings; and histologic grade. The new publication can be purchased online at www.cancerstaging.org. Older patients can benefit from lung cancer surgery NPR Older patients are frequently not offered curative treatment like surgery, because they and their families and even their doctors often think they won't be able to tolerate it. So they are referred for supportive care to control symptoms, rather than surgery to remove the cancer. But many patients can survive and even thrive after surgery, says Dr. Prasad Adusumilli, a thoracic surgeon at Memorial Sloan Kettering Cancer Center in New York. He was senior author of a study published in the Journal of Clinical Oncology in October. The study looked at more than 2,000 patients with Stage 1 non-small cell lung cancer who had surgery to remove their tumor. About 70 percent of the patients were 65 years old or older and about 30 percent were at least 75.  READ MORE    SPONSORED CONTENT Promoted by InformedDNA Drug shrinks tumors in patients with BRCA-positive breast cancer Why insurers require counseling before genetic testing Field of genetic counseling expected to grow Health care decisions challenge cancer-free, high-risk patient InformedDNA FREE Webinar: Learn How to "Strengthen Your Practice with Genetic Counseling"-Click Here to Register!   AJCC to attend RSNA AJCC If you are attending RSNA in Chicago later this month, make sure to stop by the AJCC Booth (7069) to meet AJCC staff and learn about the AJCC Cancer Staging Manual, Eighth Edition. Take this opportunity to become familiar with the changes and be prepared to implement the new staging system for cases diagnosed as of Jan. 1, 2018. Immunotherapy is curing lung cancer — who is a candidate? Forbes Scientists have long observed that our bodies' natural defense mechanisms do more than fight off nasty colds — they actually scout out and destroy foreign germs and cells meant to do us harm. It makes sense to harness these natural warriors in the fight against cancer. That's exactly how immunotherapy works.  READ MORE Scientists create innovative drug design strategy to improve breast cancer treatment Phys.Org While there have been advances in the treatment of hormone-driven breast cancer, resistance to these therapies remains a significant problem. Side effects, including an increased risk of uterine cancer among postmenopausal women, also severely curtail their use for prevention. However, a new study by scientists from the Florida campus of The Scripps Research Institute offers a novel structure-based drug design strategy aimed at altering the basic landscape of this type of breast cancer treatment.  READ MORE .  PRODUCT SHOWCASE prIME Patients by prIME Oncology prIME Patients is prIME Oncology’s resource center for patients with cancer and their caregivers. Our patient-focused videos explain, in layman’s terms, how certain treatments fight the various cancers. This information will arm you with the knowledge on what to expect during your course treatment so that you can be an informed part of the decision making team. Fecal occult blood test, colonoscopy useful for detecting dasatinib-induced colitis Oncology Nurse Advisor A fecal occult blood test followed by a colonoscopy is a useful approach for detecting hemorrhagic colitis in patients with chronic myeloid leukemia (CML) treated with dasatinib, according to a study published in the journal Blood. Some patients with CML treated with a tyrosine kinase inhibitor (TKI) test positive upon a fecal occult blood test, and hemorrhagic colitis has been reported in patients treated with dasatinib.  READ MORE Blood test could predict best treatment for lung cancer Cancer Research UK via Medical Xpress A blood test could predict how well small-cell lung cancer (SCLC) patients will respond to treatment, according to new research recently published in Nature Medicine. Scientists, based at the Cancer Research UK Manchester Institute at The University of Manchester, isolated tumor cells that had broken away from the main cancer — known as circulating tumour cells (CTCs) — from the blood of 31 patients with this aggressive form of the disease.  READ MORE     .  SPONSOR SPOTLIGHT     Announcing the Commission on Cancer 2016-2017 cancer research paper competition for physicians-in-training CoC The Commission on Cancer is hosting a paper competition for physicians-in-training to foster the importance of oncologic research in support of its mission. Papers are due June 30, 2017.  READ MORE Cyber-seminar: Cancer Caregiving in the Community National Cancer Institute More than 1.6 million Americans are expected to receive a new cancer diagnosis this year. Though cancer most strongly affects the individual, its impact extends to relatives and friends as well. Family and friends are often central in providing care or assistance in both the immediate and long-term management of cancer. Furthermore, as a result of advances in treatment and healthcare changes, much of cancer care is offered on an outpatient basis and is performed at home by caregivers. Research indicates that caregiving can be both demanding and burdensome — physically, emotionally and financially — for many cancer caregivers. The November Research to Reality cyber seminar will highlight the work of researchers and practitioners working on cancer caregiving in the community.  READ MORE    TRENDING ARTICLES Missed last week's issue? See which articles your colleagues read most. Special alert to cancer program administrators in CoC-accredited cancer programs (CoC) Important announcement about the AJCC 8th Edition (AJCC) Hospital volume linked to odds of appropriate breast cancer locoregional treatment (Oncology Nurse Advisor) General surgery residents overwhelmingly prefer flexible work hours for patient care, education (ACS) NCCN challenges medical community to 'Just Bag It' to eradicate deadly medical error (The ASCO Post) Vitamin D linked to longer breast cancer survival (The New York Times) Don't be left behind. Click here to see what else you missed.   The Brief Connect with AJCC Connect with CoC Connect with NAPBC Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version  Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit Ashley Whipple, Senior Content Editor, 469-420-2642 | Contribute news Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The CoC and NAPBC do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons, the CoC and the NAPBC. American College of Surgeons 633 N Saint Clair Street | Chicago, IL, 60611-3211  | 800-621-4111 | Contact Us  Learn how to add us to your safe sender list so our emails get to your inbox. 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063